This is a golden age for biomedical research, with novel technologies and groundbreaking science revealing new pathways to diagnose, treat, prevent, or cure disease. Yet too many patients still lack lifesaving therapies. Last year, the House Committee on Energy and Commerce launched the bipartisan 21st Century Cures initiative to consider opportunities to transform biopharmaceutical R & D.